Activating neutrophils against cancer
Activation of the immune system to fight cancer is a promising approach, but clinical efficacy has been limited. Current immunotherapy efforts focus mainly on T lymphocytes. The EU-funded CINPinCB project proposes neutrophils as an alternative cell therapeutic target as they are abundant in the tumour microenvironment. To investigate the complexity and heterogeneity of tumour-associated neutrophils, researchers propose to develop conditionally immortalised neutrophil progenitors as a cell source for experimental studies. The aim is to decipher the mechanisms that control the functions of these cells and generate new targets for immunotherapy.
Call for proposal
See other projects for this call